STERIS STE Life Sciences: — Segment operating income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by STERIS in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: STERIS’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about STERIS's life sciences: — segment operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is STERIS's life sciences: — segment operating income?
- STERIS (STE) reported life sciences: — segment operating income of $61.8M in Q4 2025.
- What does life sciences: — segment operating income mean?
- This metric measures the profitability of the Life Sciences segment after accounting for direct costs and allocated operating expenses. It serves as a primary indicator of the segment's operational health and its contribution to the overall corporate bottom line.